Drawing for RETAINE MGD ADVANCED

USPTO serial 99412241

RETAINE MGD ADVANCED

Reviewed by CopyMark Law Group

Status 748
Filing date
Status date
Registration date
—
Examiner
BALSTAD, ELIZABETH M
Law office
TMO LAW OFFICE 138

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RETAINE MGD ADVANCED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Usha Menon

Usha Menon D'AMBROSIO & MENON, PLLC3 Sugar Creek Center Blvd., Suite 100Sugar Land, TX 77478United States

Goods and services

ClassDescriptionStatusFirst use
005Ocular pharmaceuticals; Eye drops; Lubricant eye drops for the treatment of MGD or meibomian gland dysfunctionACTIVEMay 31, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 14, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 1, 2026IUAFUSE AMENDMENT FILED—
Oct 1, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 28, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 3, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 3, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 25, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 3, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 2, 2026DOCKASSIGNED TO EXAMINER—
Sep 25, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 25, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 25, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance